Literature DB >> 34211780

Radiotherapy for cervical cancer: Chilean consensus of the Society of Radiation Oncology.

Felipe Carvajal1,2, Claudia Carvajal1, Tomás Merino3,4, Verónica López1, Javier Retamales1, Evelyn San Martín5, Freddy Alarcón1, Mónica Cuevas1, Francisca Barahona1, Ignacio Véliz1, Juvenal A Ríos6, Sergio Becerra4.   

Abstract

BACKGROUND: Cervical cancer is a public health problem in Latin America. Radiotherapy plays a fundamental role both as definitive or adjuvant treatment. There are important intra and inter-country differences regarding access and availability of radiotherapy facilities in this region. The aim of a study was to standardize the basic clinical and technical criteria for the radiation treatment of patients with CC in Chile and provide a guide for Latin American Radiation Oncologists.
MATERIALS AND METHODS: Forty-one expert radiation oncologists from the Chilean Radiation Oncology Society made a consensus using the Delphi methodology.
RESULTS: There was a high degree of agreement for each of the recommendations. Those with the lowest percentage were related to the definition of the conformal 3D technique as the standard for definitive external radiotherapy (81%) and the criteria for extended nodal irradiation (85%).
CONCLUSIONS: These recommendations present an updated guide for radiotherapy treatment of patients with cervical cancer for Latin America. Those should be implemented according to local resources of each institution.
© 2021 Greater Poland Cancer Centre.

Entities:  

Keywords:  brachytherapy; consensus; radiotherapy; uterine cervical neoplasms

Year:  2021        PMID: 34211780      PMCID: PMC8241307          DOI: 10.5603/RPOR.a2021.0025

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  80 in total

1.  Reviewing the role of parametrial boost in patients with cervical cancer with clinically involved parametria and staged with positron emission tomography.

Authors:  Chrishanthi Rajasooriyar; Sylvia Van Dyk; Mery Lindawati; David Bernshaw; Srinivas Kondalsamy-Chennakesavan; Kailash Narayan
Journal:  Int J Gynecol Cancer       Date:  2012-11       Impact factor: 3.437

2.  Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.

Authors:  C W Whitney; W Sause; B N Bundy; J H Malfetano; E V Hannigan; W C Fowler; D L Clarke-Pearson; S Y Liao
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

3.  Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.

Authors:  Ajeet Kumar Gandhi; Daya Nand Sharma; Goura Kisor Rath; Pramod Kumar Julka; Vellaiyan Subramani; Seema Sharma; Durai Manigandan; M A Laviraj; Sunesh Kumar; Sanjay Thulkar
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-01       Impact factor: 7.038

4.  The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology guidelines for the management of patients with cervical cancer.

Authors:  David Cibula; Richard Pötter; François Planchamp; Elisabeth Avall-Lundqvist; Daniela Fischerova; Christine Haie Meder; Christhardt Köhler; Fabio Landoni; Sigurd Lax; Jacob Christian Lindegaard; Umesh Mahantshetty; Patrice Mathevet; W Glenn McCluggage; Mary McCormack; Raj Naik; Remi Nout; Sandro Pignata; Jordi Ponce; Denis Querleu; Francesco Raspagliesi; Alexandros Rodolakis; Karl Tamussino; Pauline Wimberger; Maria Rosaria Raspollini
Journal:  Radiother Oncol       Date:  2018-05-01       Impact factor: 6.280

5.  Adjuvant radiotherapy following radical hysterectomy for patients with stage IB and IIA cervical cancer.

Authors:  A P Soisson; J T Soper; D L Clarke-Pearson; A Berchuck; G Montana; W T Creasman
Journal:  Gynecol Oncol       Date:  1990-06       Impact factor: 5.482

6.  Overview of radiotherapy resources in Latin America: a survey by the International Atomic Energy Agency (IAEA).

Authors:  Eduardo H Zubizarreta; Adela Poitevin; C Victor Levin
Journal:  Radiother Oncol       Date:  2004-10       Impact factor: 6.280

7.  45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?

Authors:  R Mazeron; C Petit; E Rivin; E Limkin; I Dumas; P Maroun; P Annede; F Martinetti; T Seisen; D Lefkopoulos; C Chargari; C Haie-Meder
Journal:  Clin Oncol (R Coll Radiol)       Date:  2015-11-05       Impact factor: 4.126

Review 8.  Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.

Authors: 
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

9.  Radiation Therapy for Cervical Cancer: Executive Summary of an ASTRO Clinical Practice Guideline.

Authors:  Junzo Chino; Christina M Annunziata; Sushil Beriwal; Lisa Bradfield; Beth A Erickson; Emma C Fields; KathrynJane Fitch; Matthew M Harkenrider; Christine H Holschneider; Mitchell Kamrava; Eric Leung; Lilie L Lin; Jyoti S Mayadev; Marc Morcos; Chika Nwachukwu; Daniel Petereit; Akila N Viswanathan
Journal:  Pract Radiat Oncol       Date:  2020-05-18

10.  Adjuvant external beam radiation and brachytherapy for vaginal resection margin positive cervical cancer.

Authors:  Donghyun Kim; Yongkan Ki; Wontaek Kim; Dahl Park; Joohye Lee; Jayoung Lee; Hosang Jeon; Jiho Nam
Journal:  Radiat Oncol J       Date:  2018-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.